|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2-Na+-K+-ATPase subunit1Department of Molecular and Cellular Physiology and 2Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Cincinnati, Ohio
Submitted 20 February 2008 ; accepted in final form 8 May 2008
ACTH-induced-hypertension is commonly employed as a model of stress-related hypertension, and despite extensive investigation, the mechanisms underlying elevated blood pressure (BP) are not well understood. We have reported that ACTH treatment increases tail-cuff systolic pressure in wild-type mice but not in mutant mice expressing ouabain-resistant
2-Na+-K+-ATPase subunits (
2R/R mice). Since tail-cuff measurements involve restraint stress, the present study used telemetry to distinguish between an effect of ACTH on resting BP vs. an ACTH-enhanced stress response. We also sought to explore the mechanisms underlying ACTH-induced BP changes in mutant
2R/R mice vs. wild-type mice (ouabain-sensitive
2-Na+-K+-ATPase,
2S/S mice). Baseline BP was not different between the two genotypes, but after 5 days of ACTH treatment, BP increased in
2S/S (104.0 ± 2.6 to 117.7 ± 3.0 mmHg) but not in
2R/R mice (108.2 ± 3.2 to 111.5 ± 4.0 mmHg). To test the hypothesis that ACTH hypertension is related to inhibition of
2-Na+-K+-ATPase on vascular smooth muscle by endogenous cardiotonic steroids, we measured BP and regional blood flow. Results suggest a differential sensitivity of renal, mesenteric, and cerebral circulations to ACTH and that the response depends on the ouabain sensitivity of the
2-Na+-K+-ATPase. Baseline cardiac performance was elevated in
2S/S but not
2R/R mice. Overall, the data establish that the
2-Na+-K+-ATPase ouabain-binding site is of central importance in the development of ACTH-induced hypertension. The mechanism appears to be related to alterations in cardiac performance, and perhaps vascular tone in specific circulations, presumably caused by elevated levels of circulating cardiotonic steroids.
cardiac glycosides; telemetry; blood flow; vascular resistance; hemodynamics
This article has been cited by other articles:
![]() |
A. Y. Bagrov, J. I. Shapiro, and O. V. Fedorova Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets Pharmacol. Rev., March 1, 2009; 61(1): 9 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Kaplan A Natriuretic Hormone-Binding Site on the Sodium Pump J. Am. Soc. Nephrol., October 1, 2008; 19(10): 1839 - 1840. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |